ACF HIT BY GOVT COST-CUTTING MEASURES

17 May 1992

Dutch company ACF Holding was affected in 1991 by the Dutch government's measures to reduce health care costs, the company said in its 1991 annual report.

Net sales for the year were 1.24 billion guilders ($668.5 million), down 0.8% on the previous year. The small decline was attributed to the disposal by ACF of a number of companies as part of a restructuring program. ACF pointed out that companies participating in core activities achieved growth in the region of 6%.

Net profit was 23.8 million guilders, up 68.8% on the 1990 level. Operating profit declined 27.5% to 32.9 million guilders. This fall was mainly a result of divestments and start-up costs for the company's wholesale division's readjusted logistic system, and accelerated depreciation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight